Arbutus Biopharma Corp Accumulated Deferred Investment Tax Credit
Arbutus Biopharma Corp (ABUS) had Accumulated Deferred Investment Tax Credit of -$392.06 thousand as of 2013-12-31, per its 10-K filed 2014-03-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:AccumulatedDeferredInvestmentTaxCredit · last filed 2014-03-28
- 2012-12-31: Accumulated Deferred Investment Tax Credit -303.00K CAD.
- 2011-12-31: Accumulated Deferred Investment Tax Credit -973.00K CAD.
CAD
| Period end | Accumulated Deferred Investment Tax Credit |
|---|---|
| 2012-12-31 | -303.00K CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | -973.00K CAD 20-F · filed 2013-03-27 |
USD
| Period end | Accumulated Deferred Investment Tax Credit |
|---|---|
| 2013-12-31 | -$392.06K 10-K · filed 2014-03-28 |
| 2012-12-31 | -$304.55K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |